ANTIFUNGAL SUSCEPTIBILITY TESTING
- 1 December 2001
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 15 (4) , 1227-1261
- https://doi.org/10.1016/s0891-5520(05)70192-6
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusionDiagnostic Microbiology and Infectious Disease, 2000
- Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans and Cryptococcus neoformansAntimicrobial Agents and Chemotherapy, 2000
- Practice Guidelines for the Treatment of CandidiasisClinical Infectious Diseases, 2000
- Risk factors for candidemia in Neonatal Intensive Care Unit patientsThe Pediatric Infectious Disease Journal, 2000
- International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agentsDiagnostic Microbiology and Infectious Disease, 1999
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE ProgramDiagnostic Microbiology and Infectious Disease, 1998
- Evaluation of the susceptibility of pathogenicCandida species to fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.Diagnostic Microbiology and Infectious Disease, 1996
- Disseminated trichosporonosis: Meeting the challengeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991